|
Volume
19 Number 9
30 September 2017
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
19, Year 2017 >
Number 9, 30 September
|
|
|
|
|
|
Salma S, Djan I, Bjelan M,
Vulekovic P, Novakovic M, Vidovic V, Lucic M.
Benefit
and outcome of using temozolomide-based chemoradiotherapy followed
by temozolomide alone for glioblastoma in clinical practice.
J
BUON. 2017 Sep-Oct;22(5):1233-1239→.
PMID: 29135107→.
Observational study. ˍ
|
|
|
|
Nowosielski M, Ellingson BM, Chinot
OL, Garcia J, Revil C, Radbruch A, Nishikawa R, Mason WP,
Henriksson R, Saran F, Kickingereder P, Platten M, Sandmann T,
Abrey LE, Cloughesy TF, Bendszus M, Wick W.
Radiologic
progression of glioblastoma under therapy - an exploratory
analysis of AVAglio.
Neuro
Oncol. 2017 Sep 1, 2018;20(4):557-566→.
doi: 10.1093/neuonc/nox162→.
PMID: 29016943→.
Interventional study. ˍ
|
|
|
|
Phuong
PC, Hung NQ, Ngoc TB, Rades D, Khoa MT.
Rotating
Gamma System Irradiation: A Promising Treatment for Low-grade
Brainstem Gliomas.
In
Vivo. 2017 Sep 7, 2017;31(5):957-960→.
doi: 10.21873/invivo.11153→.
PMID: 28882965→.
Interventional
study. ˍ
|
|
|
|
Shi W, Scannell Bryan M, Gilbert
MR, Mehta MP, Blumenthal DT, Brown PD, Valeinis E, Hopkins K,
Souhami L, Andrews DW, Tzuk-Shina T, Howard SP, Youssef EF,
Lessard N, Dignam JJ, Werner-Wasik M.
Investigating
the Effect of Reirradiation or Systemic Therapy in Patients With
Glioblastoma After Tumor Progression: A Secondary Analysis of NRG
Oncology/Radiation Therapy Oncology Group Trial 0525.
Int
J Radiat Oncol Biol Phys. 2017 Sep 4, 2018;100(1):38-44→.
doi: 10.1016/j.ijrobp.2017.08.038→.
PMID: 29102648→.
Observational
study. ˍ
|
|
|
|
Aiken R, Axelson M, Harmenberg J,
Klockare M, Larsson O, Wassberg C.
Phase
I clinical trial of AXL1717 for treatment of relapsed malignant
astrocytomas: analysis of dose and response.
Oncotarget.
2017 Sep 6, 2017;8(46):81501-81510→.
doi: 10.18632/oncotarget.20662→.
PMID:
29113409→.
Interventional
study. ˍ
|
|
|
|
Belcher
SM, Burton CC, Cookman CJ, Kirby M, Miranda GL, Saeed FO, Wray KE.
Estrogen
and soy isoflavonoids decrease sensitivity of medulloblastoma and
central nervous system primitive neuroectodermal tumor cells to
chemotherapeutic cytotoxicity.
BMC
Pharmacol Toxicol. 2017 Sep 6, 2017;18(1):63→.
doi: 10.1186/s40360-017-0160-7→.
PMID:
28877739→.
Laboratory
investigation. ˍ
|
|
|
|
Scoccianti
S, Krengli M, Marrazzo L, Magrini SM, Detti B, Fusco V, Pirtoli L,
Doino D, Fiorentino A, Masini L, Greto D, Buglione M, Rubino G,
Lonardi F, Migliaccio F, Marzano S, Santoni R, Ricardi U, Livi L.
Hypofractionated
radiotherapy with simultaneous integrated boost (SIB) plus
temozolomide in good prognosis patients with glioblastoma: a
multicenter phase II study by the Brain Study Group of the Italian
Association of Radiation Oncology (AIRO).
Radiol
Med. 2017 Sep 6, 2018;123(1):48-62→.
doi: 10.1007/s11547-017-0806-y→.
PMID: 28879459→.
Interventional
study. ˍ
|
|
|
|
Paisan
GM, Buell TJ, Raper D, Asthagiri A.
Lumbosacral
Subdural Hematoma After Glioblastoma Multiforme Resection:
Possible Radiographic Evidence for the Downward Migration of
Intracranial Blood.
World
Neurosurg. 2017 Sep 7, 2017;108:993.e13-993.e17→.
doi: 10.1016/j.wneu.2017.08.189→.
PMID: 28890010→.
Case
report. ˍ
|
|
|
|
Hocking
MC, Hobbie W, Fisher MJ.
Development
of the Pediatric Neuro-Oncology Rating of Treatment Intensity
(PNORTI).
J
Neurooncol. 2017 Sep 8, 2018;136(1):73-78→.
doi: 10.1007/s11060-017-2618-2→.
PMID: 28887756→.
Observational
study. ˍ
|
|
|
|
Scobioala
S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am
Zehnhoff-Dinnesen A, Eich HT.
Impact
of radiation technique, radiation fraction dose, and total
cisplatin dose on hearing: Retrospective analysis of 29
medulloblastoma patients.
Strahlenther
Onkol. 2017 Sep 8, 2017;193(11):910-920→.
doi: 10.1007/s00066-017-1205-y→.
PMID: 28887665→.
Observational
study. ˍ
|
|
|
*
|
Saito
T, Sugiyama K, Hama S, Yamasaki F, Takayasu T, Nosaka R, Muragaki
Y, Kawamata T, Kurisu K.
Prognostic
importance of temozolomide-induced neutropenia in glioblastoma,
IDH-wildtype patients.
Neurosurg
Rev. 2017 Sep 9, 2018;41(2):621-628→.
doi: 10.1007/s10143-017-0903-3→.
PMID: 28887717→.
Observational
study. ˍ
|
|
|
|
Orzan
F, De Bacco F, Crisafulli G, Pellegatta S, Mussolin B, Siravegna
G, D'ambrosio A, Comoglio PM, Finocchiaro G, Boccaccio C.
Genetic
Evolution of Glioblastoma Stem-like Cells from Primary to
Recurrent Tumor.
Stem
Cells. 2017 Sep 12, 2017;35(11):2218-2228→.
doi: 10.1002/stem.2703→.
PMID: 28895245→.
Laboratory
investigation. ˍ
|
|
|
|
Jayamanne D, Wheeler H, Cook R, Teo C, Brazier D, Schembri G,
Kastelan M, Guo L, Back MF.
Survival
improvements with adjuvant therapy in patients with
glioblastoma.
ANZ J Surg. 2017 Sep 18,
2018;88(3):196-201→.
doi: 10.1111/ans.14153→.
PMID: 28922698→.
Observational study. ˍ
|
|
|
|
Bradley CA.
Glioblastoma: Stem
cells - masters of their fates.
Nat Rev
Cancer. 2017 Sep 25, 2017;17(10):574-575→.
doi: 10.1038/nrc.2017.88→.
PMID: 28943636→.
Comment. ˍ
Refers
to: Lan
X et al, Fate mapping of human glioblastoma reveals an invariant
stem cell hierarchy.
Nature. 2017 Aug 30,
2017;549(7671):227-232→.
doi: 10.1038/nature23666→.
PMID: 28854171→.
Laboratory
investigation.
ˍ
|
|
|
|
Nael K, Bauer AH, Hormigo A, Lemole M, Germano IM, Puig J, Stea B.
Multiparametric MRI for
Differentiation of Radiation Necrosis From Recurrent Tumor in
Patients With Treated Glioblastoma.
AJR Am J
Roentgenol. 2017 Sep 27, 2018;210(1):18-23→.
doi: 10.2214/AJR.17.18003→.
PMID: 28952810→.
Observational study. ˍ
|
|
|
|
|
|
|
|
|
